() () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () ()

Tag Archives: C$15 million

Wildflower Announces Private Placement of Up to $15 Million

April 12, 2019 (GLOBE NEWSWIRE) -- Wildflower Brands Inc. (CSE: SUN) (the “Company”) announces that it has entered into a brokered syndicated “best efforts” private placement led by Industrial Alliance Securities (the “Lead Agent”) with Sprott Capital Partners joining as a syndicate member (together with the Lead Agent, the “Agents”) for the sale of up to 20,000,000 subscription receipts (each a “Subscription Receipt” and collectively, the “Subscription Receipts”), at a price of $0.75 (the “Issue Price”) per Subscription Receipt (the “Offering”). The closing of the Offering is anticipated to occur on May 23, 2019 or such other date as the Agents and the Company may agree (the “Closing Date”). 
Read more

Pivot Pharma Announces C$15 million Private Placement and Strategic Partnership

April 9, 2019 /CNW/ - Pivot Pharmaceuticals Inc. (CSE: PVOT / OTCQB: PVOTF / FRA: NPAT) ("Pivot" or the "Company") is pleased to announce that it has signed a Binding Letter of Intent, dated  April 8, 2019, with High Park Ventures Inc. ("HPK" or "High Park Ventures"), a private investment company, for a non-brokered private placement of $15 million.
Read more